ut ?7.55 a month. An identical smoker would be required to pay ?13.39 per month for the same cover. Searching through most of the UK providers using a
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
"http://www.moneynet.co.uk/insurance/life-assurance/life-insurance-free-quote-form.shtml">insurance comparison site like Moneynet also provides similar results. This re
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
resents a massive difference across the life of a full policy,
Due to the higher profile which currently surrounds the subject of smoking, which has occurred recently thank
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
to the ban, many insurance companies are looking to receive a large number of requests from reformed ex-smokers asking for re-quotes to be carried out on their existing pol
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
cies. It is important to note however that to be considered as a non-smoker by most insurance companies, ex-smokers need to have refrained from any tobacco products for ov
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
r 12 months, and will probably be asked to take a simple and completely painless cotinine test.
James Yerkess, the head of Tesco Life Insurance said: "The link between smok
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
ng and early death is clear and well documented in life insurer's claims statistics”, however, “Many people aren't aware that they can ask their life insurer to re-quote the
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
r policy if they have stopped smoking for thirteen months or more. It's surprising that more companies don't seem to shout about it."
To take advantage of the potential inc
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
ease in the numbers of ex-smoking customers, Tesco has announced a 'quit for life' promise. This is a guarantee to reduce the premium of reformed smokers to that of a non s
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
oker after a period of thirteen months as long as the policyholder's general health hasn't deteriorated and they still pledge that they will continue to remain a non-smoker.
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
Research manager Amanda Sandford from the anti-smoking group, ASH stated, “We welcome any measure that encourages smokers to quit for life.” She believes that the promotion
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
of non-smoking attitudes by life insurance companies, “Clearly highlights that stopping smoking not only benefits your health but also your wallet."
Disclaimer:
All info
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
mation contained in this article, is for general information purposes only and should not be construed as advice under the Financial Services Act 1986.
You are strongly a
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products